Two Sigma Advisers
PTPI

Two Sigma Advisers’s Petros Pharmaceuticals PTPI Stock Holding History

Two Sigma Advisers’s Portfolio PTPI Stock Details PTPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-295
Closed -$115K – 2840
2022
Q1 		$115K Buy
295
+247
+515% +$104K ﹤0.01% 2482
2021
Q4 		$40K Buy
+48
New +$28.1K ﹤0.01% 2491

Other funds holding PTPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
V
Veritable Wilmington, Delaware $6.46B AUM 17.32% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return

Two Sigma Advisers's PTPI Position: Q2 2022 in Review

Two Sigma Advisers sold out of Petros Pharmaceuticals (PTPI) in Q2 2022, closing a stake of 295 shares — an estimated $115K sold.

Two Sigma Advisers first reported a position in PTPI in Q4 2021 and held it in 2 quarters. The position peaked at $115K in Q1 2022. 13 funds tracked by Wall St. Rank hold PTPI as of Q2 2022.

  • Two Sigma Advisers reported no remaining Petros Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 295 Petros Pharmaceuticals shares in Q2 2022, an estimated $115K.
  • Two Sigma Advisers first reported a position in Petros Pharmaceuticals in Q4 2021 and held it in 2 quarters.
  • Two Sigma Advisers's Petros Pharmaceuticals position peaked at $115K in Q1 2022.
  • 13 funds tracked by Wall St. Rank held Petros Pharmaceuticals as of Q2 2022.

Based on Two Sigma Advisers's 13F filing for Q2 2022, filed 15 Aug 2022.